BioVaxys Technology (BVAXF)
OTHER OTC:BVAXF
Holding BVAXF?
Track your performance easily

BioVaxys Technology (BVAXF) Balance Sheet

29 Followers

BioVaxys Technology Balance Sheet

BioVaxys Technology's total assets for Q1 2024 were C$1.77M, an increase of 19.66% from the previous quarter. BVAXF total liabilities were C$2.79M for the fiscal quarter, a -2.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Oct 23Oct 22Oct 21Oct 20Oct 19
Total Assets
C$ 113.48KC$ 865.56KC$ 8.50MC$ 10.46MC$ 306.26K
Total Liabilities
C$ 3.49MC$ 1.64MC$ 326.86KC$ 900.09KC$ 116.15K
Total Equity Gross Minority
C$ -3.37MC$ -773.53KC$ 8.18MC$ 9.56MC$ 190.11K
Total Capitalization
C$ -3.37MC$ -773.53KC$ 8.18MC$ 9.56MC$ 190.11K
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in CAD

BioVaxys Technology Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis